1. South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, SA, Australia;
2. Division of Haematology and Centre for Cancer Biology, South Australian Pathology, Adelaide, SA, Australia;
3. University of Turin, Orbassano, Italy;
4. The University of Texas MD Anderson Cancer Center, Houston, TX;
5. Institut National de la Santé et de la Recherche Médicale Centre d'Investigation Clinique 0802, Centre Hospitalier Universitaire de Poitiers, Poitiers, France;
6. University of Leipzig, Leipzig, Saxony, Germany;
7. University of Bologna, Bologna, Italy;
8. Chiba University Hospital, Chiba, Japan;
9. University of Campinas, Campinas, Brazil;
10. Cleveland Clinic, Cleveland, OH;
11. Novartis Pharma AG, Basel, Switzerland;
12. Novartis Pharmaceuticals Corporation, East Hanover, NJ;
13. University of Chicago, Chicago, IL; and
14. Abteilung Hämatologie/Onkologie, Universitätsklinikum Jena, Jena, Thuringia, Germany